ITI Securities Broking Ltd

Change Company Name

Cipla Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500087	ISIN Demat INE059A01026	Book Value 423.35	NSE Symbol CIPLA	Div & Yield % 0.99	Market Cap (₹ Cr.) 106,061.29	P/E 32.34	EPS 40.59	Face Value 2

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
SOURCES OF FUNDS :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Share Capital	161.56	161.52	161.47	161.43	161.36	161.29
Reserves Total	34,039.55	31,937.72	27,812.45	24,476.66	22,352.19	19,766.27
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	34,201.11	32,099.24	27,973.92	24,638.09	22,513.55	19,927.56
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	124.97	117.38	45.55	50.09	23.45	52.12
Total Debt	124.97	117.38	45.55	50.09	23.45	52.12
Other Liabilities	341.32	196.88	154.87	186.98	181.38	209.87
Total Liabilities	34,667.40	32,413.50	28,174.34	24,875.16	22,718.38	20,189.55
APPLICATION OF FUNDS :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Gross Block	10,499.72	8,670.09	8,045.96	7,766.42	7,388.29	7,065.54
Less : Accumulated Depreciation	5,305.91	4,792.46	4,327.33	3,957.42	3,478.37	2,999.09
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	5,193.81	3,877.63	3,718.63	3,809.00	3,909.92	4,066.45
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	977.59	638.40	670.27	504.25	267.68	355.11
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	17,616.33	17,350.99	13,793.76	11,909.35	10,973.68	9,725.83
Current Assets, Loans & Advances	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Inventories	4,353.71	3,607.12	3,254.28	3,277.36	3,485.81	3,085.81
Sundry Debtors	3,396.74	3,859.99	2,681.75	2,888.49	2,794.48	3,035.37
Cash and Bank Balance	518.60	278.45	333.20	966.46	1,428.03	874.80
Loans and Advances	2,874.53	3,774.35	4,205.02	3,467.38	1,587.92	1,191.36
Total Current Assets	11,143.58	11,519.91	10,474.25	10,599.69	9,296.24	8,187.34
Less : Current Liabilities and Provisions	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Current Liabilities	2,893.46	2,319.36	2,091.72	2,038.44	2,020.03	2,044.15
Provisions	932.23	832.86	754.53	646.74	631.39	625.13
Total Current Liabilities & Provisions	3,825.69	3,152.22	2,846.25	2,685.18	2,651.42	2,669.28
Net Current Assets	7,317.89	8,367.69	7,628.00	7,914.51	6,644.82	5,518.06
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	339.49	249.02	211.07	249.95	234.44	0.00
Deferred Tax Liability	289.26	229.14	243.71	286.08	313.69	104.91
Net Deferred Tax	50.23	19.88	-32.64	-36.13	-79.25	-104.91
Other Assets	3,511.55	2,158.91	2,396.32	774.18	1,001.53	629.01
Total Assets	34,667.40	32,413.50	28,174.34	24,875.16	22,718.38	20,189.55
Contingent Liabilities	986.05	936.62	674.73	552.80	619.71	1,700.79

Balance Sheet

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors